July 27, 2021 (ACCESSWIRE via COMTEX) -- NEW YORK, NY / ACCESSWIRE / July 27, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.
James River Group Holdings, Ltd. /zigman2/quotes/202205552/composite JRVR -16.20%
CONTACT JAKUBOWITZ ABOUT JRVR:
Class Period : August 1, 2019 - May 5, 2021
Lead Plaintiff Deadline : September 7, 2021
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) James River had not adequately reserved for its Uber policies; (2) James River was using an incorrect methodology for setting reserves that materially understated the Company's true exposure to Uber claims; (3) as a result, James River was forced to increase its unfavorable reserves in subsequent quarters even after cancelling the Uber policies; and (4) as a result of the foregoing, Defendants' statements about James River's business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.
Virgin Galactic Holdings, Inc. /zigman2/quotes/208333884/composite SPCE -2.15%
CONTACT JAKUBOWITZ ABOUT SPCE:
Class Period : October 26, 2019 - April 30, 2021
Lead Plaintiff Deadline : July 27, 2021
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) for accounting purposes, Social Capital Hedosophia Holdings Corp.'s ("SCH") warrants were required to be treated as liabilities rather than equities; (ii) Virgin Galactic had deficient disclosure controls and procedures and internal control over financial reporting; (iii) as a result, the Company improperly accounted for SCH warrants that were outstanding at the time of the business combination; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.
Frequency Therapeutics, Inc. /zigman2/quotes/214411420/composite FREQ +0.15%
CONTACT JAKUBOWITZ ABOUT FREQ:
Class Period : November 16, 2020 - March 22, 2021
Lead Plaintiff Deadline : August 2, 2021